Lupus Research Alliance News
Get Inspired!

July 17, 2018 The Lupus Research Alliance New York City Lupus Research Reception featured incredible speakers whose remarks are well worth sharing: Larry Schreiber, President of Empire BlueCross BlueShield; Meggan Mackay, MD, MS, Investigator at the Feinstein Institute for Medical Research; and Kenneth Farber, President & CEO, Lupus Research Alliance. The take-aways are clear – companies fund causes […] READ MORE

Take Survey to Help Advance Clinical Studies for New Lupus Treatments

July 3, 2018 The Lupus Research Alliance, Antidote, and SCORR Marketing are conducting a survey to learn what people with lupus and their caregivers, or care partners, think about clinical research.  Survey participation will take about 20 minutes and your answers are confidential. By answering these questions, you can help us make clinical trials easier for people willing to participate. […] READ MORE

Lupus Insight Prize Presented to Dr. Betty Diamond

The 2018 Lupus Insight Prize was awarded on June 21, 2018 to Betty Diamond, MD, Professor & Head, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research for her groundbreaking work in lupus nephritis. Through the Lupus Insight Prize, the Lupus Research Alliance awards $100,000 in recognition of major insights and […] READ MORE

Successful Advocacy Bringing Millions in Research Dollars to Lupus

June 28, 2018 With an overwhelming majority vote of 359 to 49, the House of Representatives just passed a bill to allocate $5 million to the Defense Department’s Congressionally Directed Medical Research Program for lupus in the 2019 budget.  This federal support of lupus research is a result of advocacy by lupus patients, organizations like […] READ MORE

Lupus Research Alliance Investment in Innovation Delivers Results

June 27, 2018 This new issue of the Lupus Research Update (LRU) takes you behind the scenes of some of the most groundbreaking research and how the Lupus Research Alliance raises the funds that enable diverse and accomplished scientists to pioneer new studies in the field. Featured in this LRU, Penn State researcher Dr. Laura […] READ MORE

Baricitinib Shows Positive Results for SLE in Phase 2 Study

June 19, 2018 Once-daily oral baricitinib 4 mg was associated with significant clinical improvements compared with placebo in patients with systemic lupus erythematosus (SLE) receiving standard background therapy, according to data presented at the European League Against Rheumatism (EULAR) Congress held in Amsterdam, June 13 to 16, 2018…. A significantly greater percentage of patients in the […] READ MORE

2018 Lupus Insight Prize Presented to Dr. Betty Diamond

2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus June 21, 2018 The Lupus Research Alliance has awarded its 2018 Lupus Insight Prize to Betty Diamond, MD, for a project to test commonly used drugs for high blood pressure as potential treatments for cognitive and emotional […] READ MORE

Department of Defense Lupus Research Program Supported in New Bill

June 13, 2018 Our advocates knocked on Capitol doors in March with requests to robustly fund the Lupus Research Program first established last year within the Defense Department’s Congressionally Directed Medical Research Programs. And our nation’s legislators listened! As a result of advocacy by lupus patients, organizations like the Lupus Research Alliance and supportive Members […] READ MORE

2017-18 Research Portfolio Summary

June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […] READ MORE

Blood Markers Identify Lupus Risk, Feinstein Institute Researchers Find

June 1, 2018 Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from early […] READ MORE

Together, ManyOne Can make a difference!